At present, the relationship between SCN1A and SCN2A polymorphisms and the efficacy of VPA in the treatment of epilepsy in children are still controversial.[12–15] So far, no meta-analysis on the relationship between SCN1A and SCN2A polymorphisms and the response of VPA to childhood epilepsy can be detected. Here, SCN1A is linked to epilepsy.